Loghavi Sanam, Walts Ann E, Bose Shikha
Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Diagn Cytopathol. 2013 Jul;41(7):582-7. doi: 10.1002/dc.22900. Epub 2012 Jul 26.
ASC and LSIL comprise the majority of abnormal Pap smears. Currently, high-risk human papillomavirus testing is utilized to triage women with ASC for colposcopy; however, no cost effective triage method is available for LSIL. p16 and Ki-67 have each been shown to be good biomarkers for high grade cervical intraepithelial neoplasia (HG CIN).We evaluated the role of the CINtec® PLUS p16/Ki-67 dual immunostain as a marker for underlying (U) or subsequent (S) HG CIN. One hundred and eighty eight cervical SurePath Pap smears with histological and/or cytological follow-up were retrieved from our departmental files. The Pap stained slides were destained and then immunostained utilizing the CINtec® PLUS dual staining reagent kit. Results of the dual stain were correlated with follow-up diagnoses. Sensitivity, specificity, and positive and negative predictive values of CINtec® PLUS for U or S HG CIN were compared with those of HR HPV testing and with p16 and Ki-67 immunostaining alone. The sensitivity of CINtec® PLUS for U or S HG CIN was 91% in the ASC group and 100% in the LSIL group, while the corresponding specificities were 61 and 43%, respectively. The sensitivity and specificity of CINtec® PLUS for U or S HG CIN in both groups combined were 97 and 53%, respectively. CINtec® PLUS was more specific than HR HPV testing and Ki-67 and p16 immunostains alone in detecting an U or S HG CIN. CINtec® PLUS is a helpful adjunct in identifying U or S HG CIN when applied to SurePath Pap smears with ASC or LSIL.
非典型鳞状细胞(ASC)和低度鳞状上皮内病变(LSIL)构成了大多数异常巴氏涂片。目前,高危型人乳头瘤病毒检测用于对ASC女性进行分流以进行阴道镜检查;然而,对于LSIL尚无具有成本效益的分流方法。p16和Ki-67均已被证明是高级别宫颈上皮内瘤变(HG CIN)的良好生物标志物。我们评估了CINtec® PLUS p16/Ki-67双重免疫染色作为潜在(U)或后续(S)HG CIN标志物的作用。从我们科室档案中检索出188例有组织学和/或细胞学随访的宫颈SurePath巴氏涂片。将巴氏染色的玻片脱色,然后使用CINtec® PLUS双重染色试剂盒进行免疫染色。双重染色结果与随访诊断相关。将CINtec® PLUS对U或S HG CIN的敏感性、特异性以及阳性和阴性预测值与高危型人乳头瘤病毒检测以及单独的p16和Ki-67免疫染色的结果进行比较。CINtec® PLUS对ASC组U或S HG CIN的敏感性为91%,对LSIL组为100%,而相应的特异性分别为61%和43%。两组合并后CINtec® PLUS对U或S HG CIN的敏感性和特异性分别为97%和53%。在检测U或S HG CIN方面,CINtec® PLUS比高危型人乳头瘤病毒检测以及单独的Ki-67和p16免疫染色更具特异性。当应用于ASC或LSIL的SurePath巴氏涂片时,CINtec® PLUS在识别U或S HG CIN方面是一种有用的辅助手段。